Scribe Therapeutics position history
The shares of Scribe Therapeutics that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q3: 786,921 shares, $14M, 0.08% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|